YieldBI for Health & Wellness

Health and wellness is one of the few categories where the ad that would work best is often the ad you are not allowed to run. That single fact shapes everything else about how these accounts should be operated.

The policy constraint comes first

Meta’s personal-attributes policy prohibits creative that implies knowledge of a person’s health condition, body, or medical history. In practice this rules out a lot of copy that reads as perfectly ordinary marketing:

• Second-person framing that asserts a condition. “Struggling with your weight?” implies Meta told you something about the viewer. “A routine built for slow mornings” does not.
• Before-and-after imagery, and idealized body comparisons generally.
• Claims about outcomes that read as medical rather than descriptive.

The rules are enforced by automated review at scale, which means they are applied inconsistently at the margin. An ad that passed last month can be rejected this month with no change to the creative. Budget for that. Treat rejections as a normal operating cost rather than an incident.

The reframe that works: describe the product and the routine, not the viewer. First-person and third-person framing survives review far better than second-person diagnosis, and, for what it is worth, tends to read as less presumptuous to the person seeing it anyway.

The second constraint is speed of burn

Wellness audiences are large, competitive, and heavily advertised to. Creative in this category tends to fatigue faster than in most others, because the same person is being served a dozen adjacent products in the same week.

The tell is not falling ROAS, which arrives late. It is CTR declining while frequency climbs: a divergence you can read within days on an ad set that has already cleared learning. If frequency is flat and CTR is dropping, that is a different problem and the creative is not the thing to change.

Because burn is fast, the pipeline matters more than any individual ad. An account with one excellent ad and nothing behind it is in a worse position than an account with three good ads and a queue, and it will find that out at the worst possible moment.

What tends to differentiate creative here

The distinction worth testing is not format. It is which of these the ad is doing:

Mechanism. Explaining why the product works. Higher intent, narrower appeal, converts better on warm traffic and expensive audiences.

Routine. Showing the product inside a day. Broad appeal, lower stated intent, tends to do the heavy lifting on cold prospecting.

Attestation. UGC and creator formats where a real person reports their experience. Usually the strongest performer, and the one that runs closest to the policy line: testimonial language slips into implied claims easily, so this is where review costs are highest.

Most accounts over-index on one of the three and never discover the other two work. Testing across the categories rather than across formats within one category is where the surprises are.

The measurement trap

Wellness businesses are usually subscription or repeat-purchase, which means first-order ROAS systematically understates a good ad. An ad acquiring customers at break-even on order one can be the most profitable thing in the account by order three.

If you optimize on first-order ROAS alone, you will predictably cut your best acquisition creative in favour of ads pulling one-off discount buyers. Judging against contribution margin and LTV instead is the difference, and it usually reverses the ranking.

Where YieldBI fits

YieldBI generates variants inside whatever creative constraints you set, so higher testing volume does not translate into more policy rejections. Fatigue signals are read at ad level daily rather than waiting for the account average to move, and the profit goal can be set against contribution rather than first-order revenue, so the ads that look mediocre on day one and excellent by month three are not quietly killed before they get there.